AlphaStocks
6.5
Consider Buy

Lantheus Holdings, Inc. (LNTH)

As of Sep 19, 2026, Lantheus Holdings, Inc. (LNTH) scores 6.5/10 on AlphaStocks' five-model composite, #29 of 168 Health Care stocks. At $101, LNTH trades 10% below its model fair value of $112.

Health Care / Health Care Supplies

S&P MidCap 400

$100.59

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 19, 2026

#29out of 168 in Health Care

Is Lantheus Holdings, Inc. a Good Investment in 2026?

Lantheus Holdings, Inc. (LNTH) scores 6.5 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Lantheus Holdings, Inc. as Attractive (5/9). However, the Graham model rates it Caution — Significantly above fair value. Lantheus Holdings, Inc. currently trades 10% below its estimated fair value of $112. Lantheus Holdings, Inc. ranks #29 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E29.5ROE21.1Market Cap7B

Estimated Fair Value

$111.9710% below

Trading slightly below estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Neutral

PEG 1.3 · Fast Grower

Greenblatt

Neutral

Earnings yield 4.2% · ROC 43%

Frequently Asked Questions

Is Lantheus Holdings, Inc. (LNTH) a good investment?
As of Sep 19, 2026, Lantheus Holdings, Inc. (LNTH) scores 6.5/10 on AlphaStocks' five-model composite, #29 of 168 Health Care stocks. At $101, LNTH trades 10% below its model fair value of $112. That is a middle-of-the-pack score with no strong signal either way.
What is Lantheus Holdings, Inc.'s Piotroski F-Score?
Lantheus Holdings, Inc.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is LNTH overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $112, LNTH appears undervalued. The stock currently trades 10% below its estimated fair value. Trading slightly below estimated fair value.
How does LNTH compare to other Health Care stocks?
Lantheus Holdings, Inc. ranks #29 out of 168 stocks in the Health Care sector, placing it in the top 17% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about LNTH?
AlphaStocks evaluates LNTH using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 6.5/10.

Similar Stocks

Compare LNTH with

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer